| S. No. |
Glycan Composition |
Glycan Mass |
Glycan Structure |
| 1 | (Fuc)1 (GlcNAc)2 (Man)3 | 1056.39 | |
| 2 | (GlcNAc)2 (Man)6 | 1396.49 | |
| 3 | (Gal)2 (GlcNAc)4 (Man)3 (NeuAc)1 | 1931.69 | |
| 4 | (Gal)3 (GlcNAc)5 (Man)3 (NeuAc)2 | 2587.92 | |
| 5 | (Gal)1 (GlcNAc)3 (Man)5 | 1599.57 | |
| 6 | (Gal)3 (GlcNAc)5 (Man)3 | 2005.73 | |
| 7 | (Fuc)1 (Gal)4 (GlcNAc)4 (Man)3 | 2110.76 | |
| 8 | (Fuc)1 (Gal)3 (GlcNAc)5 (Man)3 | 2151.79 | |
| 9 | (Fuc)1 (Gal)6 (GlcNAc)8 (Man)3 | 3247.19 | |
| 10 | (GlcNAc)2 (Man)4 | 1072.38 | |
| 11 | (Glc)3 (GlcNAc)2 (Man)7 | 2044.7 | |
| 12 | (GlcNAc)2 (Man)3 | 910.33 | |
| 13 | (Fuc)1 (Gal)5 (GlcNAc)7 (Man)3 (NeuAc)4 | 4046.44 | |
| 14 | (Fuc)1 (Gal)7 (GlcNAc)9 (Man)3 (NeuAc)4 | 4776.71 | |
| 15 | (Fuc)1 (Gal)4 (GlcNAc)6 (Man)3 (NeuAc)3 | 3390.21 | |
| 16 | (Fuc)1 (Gal)4 (GlcNAc)6 (Man)3 (NeuAc)3 | 3390.21 | |
| 17 | (Fuc)1 (Gal)6 (GlcNAc)8 (Man)3 (NeuAc)3 | 4120.48 | |
| 18 | (Fuc)1 (Gal)4 (GlcNAc)6 (Man)3 (NeuAc)2 | 3099.11 | |
| 19 | (Fuc)1 (Gal)4 (GlcNAc)6 (Man)3 (NeuAc)2 | 3099.11 | |
| 20 | (Fuc)1 (Gal)5 (GlcNAc)7 (Man)3 (NeuAc)3 | 3755.34 | |
| 21 | (Fuc)1 (Gal)5 (GlcNAc)7 (Man)3 (NeuAc)3 | 3755.34 | |
| 22 | (Fuc)1 (Gal)5 (GlcNAc)7 (Man)3 (NeuAc)3 | 3755.34 | |
| 23 | (Fuc)1 (Gal)3 (GlcNAc)5 (Man)3 (NeuAc)2 | 2733.98 | |
| 24 | (Fuc)1 (Gal)5 (GlcNAc)7 (Man)3 (NeuAc)3 | 3755.34 | |
| 25 | (Fuc)1 (Gal)6 (GlcNAc)8 (Man)3 (NeuAc)3 | 4120.48 | |
| 26 | (GlcNAc)2 (Man)5 | 1234.44 | |
| 27 | (Fuc)1 (Gal)2 (GlcNAc)4 (Man)3 (NeuAc)1 (NeuGc)1 | 2384.84 | |
| 28 | (Fuc)1 (Gal)2 (GlcNAc)4 (Man)3 (NeuAc)1 (NeuGc)1 | 2384.84 | |
| 29 | (Gal)1 (GlcNAc)3 (Man)4 | 1437.52 | |
| 30 | (Fuc)1 (Gal)3 (GlcNAc)5 (Man)3 (NeuAc)2 | 2733.98 | |
| 31 | (Ac)1 (Fuc)1 (Gal)3 (GlcNAc)5 (Man)3 (NeuAc)3 | 3067.09 | |
| 32 | (Fuc)1 (Gal)3 (GlcNAc)5 (Man)3 (NeuAc)2 (NeuGc)1 | 3041.07 | |
| 33 | (Ac)1 (Fuc)1 (Gal)3 (GlcNAc)5 (Man)3 (NeuAc)3 | 3067.09 | |
| 34 | (Fuc)1 (Gal)3 (GlcNAc)5 (Man)3 (NeuAc)2 (NeuGc)1 | 3041.07 | |
| 35 | (Fuc)1 (Gal)3 (GlcNAc)5 (Man)3 (NeuAc)3 | 3025.08 | |
| 36 | (Ac)1 (Fuc)1 (Gal)4 (GlcNAc)6 (Man)3 (NeuAc)4 | 3723.32 | |
| 37 | (Fuc)1 (Gal)4 (GlcNAc)6 (Man)3 (NeuAc)3 (NeuGc)1 | 3697.3 | |
| 38 | (Fuc)1 (Gal)4 (GlcNAc)6 (Man)3 (NeuAc)4 | 3681.31 | |
| 39 | (Fuc)1 (Gal)6 (GlcNAc)8 (Man)3 (NeuAc)4 | 4411.57 | |
| 40 | (Fuc)1 (Gal)5 (GlcNAc)7 (Man)3 (NeuAc)4 | 4046.44 | |
| 41 | (Gal)1 (GlcNAc)3 (Man)4 (NeuAc)1 | 1728.61 | |
| 42 | (GlcNAc)2 (Man)10 | 2044.7 | |
| 43 | (Gal)1 (GlcNAc)3 (Man)5 (NeuAc)1 | 1890.67 | |
| 44 | (Fuc)1 (Gal)4 (GlcNAc)6 (Man)3 (NeuAc)4 | 3681.31 | |
| 45 | (Gal)2 (GlcNAc)4 (Man)3 (NeuAc)2 | 2222.79 | |
| 46 | (Fuc)1 (Gal)3 (GlcNAc)5 (Man)3 (NeuAc)2 | 2733.98 | |
| 47 | (Fuc)1 (Gal)3 (GlcNAc)5 (Man)3 (NeuAc)1 | 2442.88 | |
| 48 | (Fuc)1 (Gal)3 (GlcNAc)5 (Man)3 (NeuAc)1 | 2442.88 | |
| 49 | (Fuc)1 (Gal)3 (GlcNAc)5 (Man)3 (NeuAc)1 | 2442.88 | |
| 50 | (Fuc)1 (Gal)4 (GlcNAc)6 (Man)3 (NeuAc)3 | 3390.21 | |
| 51 | (Fuc)1 (Gal)3 (GlcNAc)5 (Man)3 (NeuAc)2 | 2733.98 | |
| 52 | (Fuc)1 (Gal)4 (GlcNAc)6 (Man)3 (NeuAc)3 | 3390.21 | |
| 53 | (Fuc)1 (Gal)4 (GlcNAc)6 (Man)3 (NeuAc)3 | 3390.21 | |
| 54 | (Fuc)1 (Gal)4 (GlcNAc)6 (Man)3 (NeuAc)3 | 3390.21 | |
| 55 | (Fuc)1 (Gal)3 (GlcNAc)5 (Man)3 (NeuAc)2 | 2733.98 | |
| 56 | (Fuc)1 (Gal)3 (GlcNAc)5 (Man)3 (NeuAc)2 | 2733.98 | |
| 57 | (Fuc)1 (Gal)3 (GlcNAc)5 (Man)3 (NeuAc)2 | 2733.98 | |
| 58 | (Fuc)1 (Gal)3 (GlcNAc)5 (Man)3 (NeuAc)2 | 2733.98 | |
| 59 | (Fuc)1 (Gal)3 (GlcNAc)5 (Man)3 (NeuAc)3 | 3025.08 | |
| 60 | (Fuc)1 (Gal)3 (GlcNAc)5 (Man)3 (NeuAc)3 | 3025.08 | |
| 61 | (Fuc)1 (Gal)4 (GlcNAc)6 (Man)3 (NeuAc)4 | 3681.31 | |
| 62 | (Fuc)3 (Gal)2 (GlcNAc)4 (Man)3 (NeuAc)2 | 2660.96 | |
| 63 | (GlcNAc)2 (Man)7 | 1558.54 | |
| 64 | (Fuc)1 (Gal)3 (GlcNAc)5 (Man)3 | 2151.79 | |
| 65 | (Gal)3 (GlcNAc)5 (Man)3 | 2005.73 | |
| 66 | (Fuc)1 (Gal)4 (GlcNAc)6 (Man)3 | 2516.92 | |
| 67 | (Fuc)1 (Gal)3 (GlcNAc)5 (Man)3 | 2151.79 | |
| 68 | (Fuc)1 (Gal)2 (GlcNAc)4 (Man)3 (NeuAc)1 | 2077.75 | |
| 69 | (Gal)2 (GlcNAc)4 (Man)3 (NeuAc)1 | 1931.69 | |
| 70 | (Fuc)1 (Gal)2 (GlcNAc)4 (Man)3 (NeuAc)1 | 2077.75 | |
| 71 | (Fuc)1 (Gal)2 (GlcNAc)4 (Man)3 (NeuAc)2 | 2368.85 | |
| 72 | (Fuc)1 (Gal)3 (GlcNAc)5 (Man)3 (NeuAc)3 | 3025.08 | |
| 73 | (GlcNAc)2 (Man)5 | 1234.44 | |
| 74 | (Fuc)1 (GlcNAc)5 (Man)3 | 1665.63 | |
| 75 | (Gal)2 (GlcNAc)4 (Man)3 | 1640.6 | |
| 76 | (Fuc)1 (Gal)2 (GlcNAc)4 (Man)3 (NeuAc)2 | 2368.85 | |
| 77 | (GlcNAc)4 (Man)3 | 1316.49 | |
| 78 | (Gal)4 (GlcNAc)6 (Man)3 | 2370.86 | |
| 79 | (GlcNAc)2 (Man)6 | 1396.49 | |
| 80 | (GlcNAc)2 (Man)8 | 1720.6 | |
| 81 | (Fuc)1 (GlcNAc)4 (Man)3 | 1462.55 | |
| 82 | (Fuc)1 (Gal)2 (GlcNAc)4 (Man)3 | 1786.66 | |
| 83 | (Fuc)1 (GlcNAc)2 (Man)5 | 1380.5 | |
| 84 | (Fuc)1 (GlcNAc)5 (Man)3 | 1665.63 | |
| 85 | (Gal)3 (GlcNAc)5 (Man)3 (NeuAc)3 | 2879.02 | |
| 86 | (Gal)4 (GlcNAc)6 (Man)3 (NeuAc)4 | 3535.25 | |
| 87 | (GlcNAc)2 (Man)7 | 1558.54 | |
| 88 | (Fuc)1 (Gal)1 (GlcNAc)4 (Man)3 | 1624.6 | |
| 89 | (Gal)2 (GlcNAc)4 (Man)3 (NeuAc)2 | 2222.79 | |
| 90 | (GlcNAc)2 (Man)9 | 1882.65 | |
| 91 | (Glc)3 (GlcNAc)2 (Man)5 | 1720.6 | |
| 92 | (Gal)3 (GlcNAc)5 (Man)3 (NeuAc)3 | 2879.02 | |
| 93 | (GlcNAc)2 (Man)4 | 1072.38 | |
| 94 | (GlcNAc)2 (Man)8 | 1720.6 | |
| 95 | (GlcNAc)2 (Man)8 | 1720.6 | |
| 96 | (Glc)3 (GlcNAc)2 (Man)9 | 2368.81 | |
| 97 | (Glc)1 (GlcNAc)2 (Man)9 | 2044.7 | |
| 98 | (Glc)2 (GlcNAc)2 (Man)9 | 2206.76 | |
| 99 | (Fuc)1 (GlcNAc)2 (Man)3 | 1056.39 | |
| 100 | (GlcNAc)2 (Man)3 | 910.33 | |
| 101 | (GlcNAc)2 (Man)6 | 1396.49 | |
| 102 | (GlcNAc)3 (Man)3 | 1113.41 | |
| 103 | (Fuc)1 (GlcNAc)3 (Man)3 | 1259.47 | |
| 104 | (GlcNAc)4 (Man)3 | 1316.49 | |
| 105 | (Fuc)1 (GlcNAc)4 (Man)3 | 1462.55 | |
| 106 | (Fuc)1 (GlcNAc)5 (Man)3 | 1665.63 | |
| 107 | (GlcNAc)2 (Man)5 | 1234.44 | |
| 108 | (Fuc)1 (Gal)1 (GlcNAc)3 (Man)3 | 1421.52 | |
| 109 | (Gal)1 (GlcNAc)4 (Man)3 | 1478.54 | |
| 110 | (Fuc)1 (GlcNAc)5 (Man)3 | 1665.63 | |
| 111 | (Fuc)1 (Gal)1 (GlcNAc)4 (Man)3 | 1624.6 | |
| 112 | (Fuc)1 (Gal)1 (GlcNAc)5 (Man)3 | 1827.68 | |
| 113 | (Fuc)1 (Gal)1 (GlcNAc)3 (Man)3 (NeuAc)1 | 1712.62 | |
| 114 | (Fuc)1 (Gal)1 (GlcNAc)5 (Man)3 | 1827.68 | |
| 115 | (Fuc)1 (GlcNAc)3 (Man)5 | 1583.58 | |
| 116 | (Fuc)1 (Gal)1 (GlcNAc)4 (Man)3 (NeuAc)1 | 1915.7 | |
| 117 | (Fuc)1 (Gal)1 (GlcNAc)5 (Man)3 (NeuAc)1 | 2118.78 | |
| 118 | (Fuc)1 (Gal)2 (GlcNAc)4 (Man)3 | 1786.66 | |
| 119 | (Gal)1 (GlcNAc)3 (Man)5 | 1599.57 | |
| 120 | (Fuc)1 (Gal)1 (GlcNAc)3 (Man)4 (NeuAc)1 | 1874.67 | |
| 121 | (Fuc)1 (Gal)2 (GlcNAc)5 (Man)3 | 1989.74 | |
| 122 | (GlcNAc)2 (Man)7 | 1558.54 | |
| 123 | (Fuc)1 (Gal)2 (GlcNAc)4 (Man)3 (NeuAc)1 | 2077.75 | |
| 124 | (Gal)1 (GlcNAc)3 (Man)5 (NeuAc)1 | 1890.67 | |
| 125 | (Gal)1 (GlcNAc)3 (Man)5 (NeuAc)1 | 1890.67 | |
| 126 | (Fuc)1 (Gal)3 (GlcNAc)4 (Man)3 | 1948.71 | |
| 127 | (Fuc)1 (Gal)2 (GlcNAc)4 (Man)3 (NeuAc)2 | 2368.85 | |
| 128 | (Gal)3 (GlcNAc)4 (Man)3 (NeuAc)2 | 2384.84 | |
| 129 | (Gal)2 (GlcNAc)4 (Man)3 (NeuAc)1 (NeuGc)1 | 2238.78 | |
| 130 | (GlcNAc)2 (Man)9 | 1882.65 | |
Ref: Song, T., Ozcan, S., Becker, A. and Lebrilla, C.B., 2014. In-depth method for the characterization of glycosylation in manufactured recombinant monoclonal antibody drugs. Analytical chemistry, 86(12), pp.5661-5666.
